Articles

Flexible work and EPL risk: lessons from recent Fair Work Commission decisions

Read article

Insights

There is always something exciting happening at Lockton. Here are just a few from our newsroom.

1 / 6
Articles

Flexible work and EPL risk: lessons from recent Fair Work Commission decisions

Hybrid work is facing new pressures Since the COVID-19 pandemic, many workplaces are encouraging employees to return to the office to reinforce the importance of collaborative, face-to-face work and promote a positive workplace culture. As a result, …

Read Article
Case Studies

Professional & Executive Risk Quarterly Market Update: March 2026

Interpreting the insurance market: what decision‑makers need to know Australia’s insurance market is entering a more stable phase, but stability doesn’t mean simplicity. Click here for our latest edition, which explores how insurers are really mak …

Read Article
Articles

Directors and officers: governing with confidence in a high-stakes environment

Australia’s resources and mining sector plays a foundational role in the national economy. It is also one of the most scrutinised, regulated, and operationally complex industries in which to serve as a director or officer. The challenge for directors …

Read Article
Articles

How risk is changing across hotel assets

As published in the Urban Developer. Australia’s hotel sector remains a compelling investment class, but as assets become more complex, so too does the risk profile that underpins them. Risk in hotels rarely sits in one place Hotel risk does not exis …

Read Article
Articles

NSW releases new Code of Practice for healthcare and social assistance

Following Safe Work Australia’s draft release in July 2025, NSW has become the first state to formally adopt the Healthcare and Social Assistance Industry Code of Practice (the Code). The Code is approved under section 274 of the Work Health and Safe …

Read Article
Articles

Re-thinking D&O liability for life sciences companies

Life Sciences state of play In the fast-moving world of medtech, biotech, and pharmaceuticals, directors and executives navigate a landscape defined by scientific complexity, regulatory scrutiny, and heightened stakeholder expectations. These factor …

Read Article

Recent News

news-thumb-desktopnews-thumb-mobile
Read Article news